ProJenX Receives European Authorization for First Study of Prosetin in People Living with ALS

/PRNewswire/ -- ProJenX, a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the...

Related Keywords

Canada ,Erin Fleming ,Prnewswire Projen ,European Union ,Health Canada ,Treatment Research Initiative To Cure ,Columbia University ,Chief Operating Officer ,Treatment Research Initiative ,Projenx ,Biotechnology ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,